About Panacea Biotec
Panacea Biotec is a company based in Ambala (India) founded in 1984. The company has 1,290 employees as of March 31, 2024. Panacea Biotec operates in a competitive market with competitors including Abzena, Patheon, Syngene, Piramal Group and Maravai Life Sciences, among others.
- Headquarter Ambala, India
- Employees 1290 as on 31 Mar, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Panacea Biotec Limited
-
Annual Revenue
$57.82 M (USD)-10.89as on Mar 31, 2025
-
Net Profit
-$979.71 K (USD)-613.55as on Mar 31, 2025
-
EBITDA
-$5.89 M (USD)-322.07as on Mar 31, 2025
-
Latest Funding Round
$144 M (USD), Post-IPO
Apr 01, 2019
- Investors
-
Employee Count
1290
as on Mar 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Panacea Biotec
Panacea Biotec is a publicly listed company on the NSE with ticker symbol PANACEABIO in India, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
People of Panacea Biotec
Unlock access to complete
Unlock access to complete
Funding Insights of Panacea Biotec
Investors in Panacea Biotec
Panacea Biotec has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include India Resurgence Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Distressed and special situations investments across various sectors in India.
|
Locked | Locked | Locked |
Investor details for Panacea Biotec
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Panacea Biotec
Investment portfolio details for Panacea Biotec
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Panacea Biotec
Detailed financials for Panacea Biotec
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Panacea Biotec Comparisons
Peer comparison for Panacea Biotec
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Panacea Biotec
Panacea Biotec operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Abzena, Patheon, Syngene, Piramal Group and Maravai Life Sciences, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of antibody discovery, cell line development, and bio analytics services
|
|
| Locked | Locked | Locked |
Commercial manufacturing and pharmaceutical development services for biopharmaceutical industry
|
|
| Locked | Locked | Locked |
Provider of contract research and manufacturing services for both small molecules and biologics
|
|
| Locked | Locked | Locked |
Multinational conglomerate with diverse interests in Pharma, Financial Services and Real Estate
|
|
| Locked | Locked | Locked |
Provides enabling tools and services in the life sciences research and bio-production industries
|
Detailed competitors of Panacea Biotec
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Panacea Biotec
Complete news archive for Panacea Biotec
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Panacea Biotec
Panacea Biotec was founded in 1984 and raised its 1st funding round 27 years after it was founded.
Panacea Biotec is headquartered in Ambala, India. It is registered at Ambala, Haryana, India.
As of Mar 31, 2024, the latest employee count at Panacea Biotec is 1,290.
Annual revenue of Panacea Biotec is $57.82M as on Mar 31, 2025.
Panacea Biotec involved in research, manufacturing and marketing of branded pharmaceutical formulations, vaccines, biosimilars (antibodies, proteins) and natural products. The product portfolio includes prescription products in therapeutic areas like pain management, diabetes, cardiovascular management, renal disease management, osteoporosis management, anti-tubercular, gastrointestinal care products and vaccines.
Panacea Biotec's top competitors include Abzena, Syngene and Grand River Aseptic Manufacturing.
Yes, Panacea Biotec is publicly traded on NSE under the ticker symbol PANACEABIO.
Panacea Biotec has 1 investor. Key investors include India Resurgence Fund.
The ticker symbol of Panacea Biotec is PANACEABIO on NSE.